Top Markets
#1 MowCat MowCat +26.83%
#2 OriginTrail OriginTrail +20.91%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +20.26%
#4 Pons Pons +14.01%
#5 Wrapped NXM Wrapped NXM +10.13%
#6 Collector Crypt Collector Crypt +7.35%
#7 Geodnet Geodnet +7.05%
#8 Hydration Hydration +6.06%
#9 MarsCoin MarsCoin +4.96%
#10 Pharos Pharos +4.80%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Pardes Biosciences, Inc. Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

PRDS
Clasificación en acciones #20774
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated... Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes for patients battling life-threatening illnesses. Its primary investigational therapy, PBI-0451, is currently progressing through clinical development with the aim of both treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and their related health issues. Established in 2020, Pardes Biosciences maintains its corporate headquarters in Carlsbad, California.
Precio por acción
$2.16
Última sincronización: 2023-09-08
Capitalización bursátil
$122.36M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Pardes Biosciences, Inc. (PRDS)

Categoría

Healthcare
Ratio P/B de Pardes Biosciences, Inc. (PRDS)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Pardes Biosciences, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Pardes Biosciences, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH